<?xml version="1.0" encoding="UTF-8"?>
<ref id="B148-marinedrugs-17-00374" class="ref">
 <label class="label">148.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Romano</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cucchiara</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Barabino</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Annese</surname>
    <given-names class="given-names">V.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sferlazzas</surname>
    <given-names class="given-names">C.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohnâ€™s disease: A double-blind, randomized, placebo-controlled study</article-title>
  <source class="source">World J. Gastroenterol.</source>
  <year class="year">2005</year>
  <volume class="volume">11</volume>
  <fpage class="fpage">7118</fpage>
  <lpage class="lpage">7121</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.3748/wjg.v11.i45.7118</pub-id>
  <?supplied-pmid 16437657?>
  <pub-id pub-id-type="pmid" class="pub-id">16437657</pub-id>
 </element-citation>
</ref>
